-
The WHO declares the worldwide well being emergency of Covid-19 over
Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), speaks during a news conference December 20, 2021 in Geneva, Switzerland. Denis Balibouse | Reuters The spread of Covid-19 is no longer a global public health emergency, the World Health Organization said on Friday. “For more than a year, the pandemic has been on a…
-
CDC could have much less information after the emergency ends
People walk past a Covid-19 testing site in Times Square on May 12, 2022 in New York City. Liao pan | China news service | Getty Images The Centers for Disease Control and Prevention will have less data to track the spread of Covid-19 and new variants in the US after the public health emergency…
-
CDC director Rochelle Walensky will step down in June
Rochelle Walensky, director of the Centers for Disease Control, leaves the office after speaking before the Senate Committee on Health, Education, Labor and Pensions on the All-Hazards Preparedness Act Thursday, April 4. Kent Nishimura | Los Angeles Times | Getty Images CDC Director Dr. Rochelle Walensky announced on Friday that she would step down at…
-
Outcomes from Moderna (MRNA) Q1 2023
Modern on Thursday topped estimates for first-quarter earnings and revenue and posted a surprise quarterly profit despite lower demand for Covid vaccines, the only marketable product. The biotech posted revenue of $1.9 billion in the first quarter, driven by Covid-shot earnings pushed back from 2022. That’s more than 60% down from the $6.1 billion it…
-
Costs, what you need to learn about Shopper Well being Spinoff
Johnson & Johnson products on a shelf in a store in New York. Luca Jackson | Reuters Johnson & Johnson’s Consumer health company Kenvue valued its IPO Wednesday at $22 per share, at the high end of its quoted range, in a boosted deal that would raise about $3.8 billion. At this IPO price, the…
-
Eli Lilly therapy with donanemab slowed illness development
An Eli Lilly and Company pharmaceutical manufacturing facility is pictured at 50 ImClone Drive on March 50, 2021 in Branchburg, New Jersey. Fresh Mike | Reuters The Alzheimer’s treatment Donanemab, which is manufactured by Eli Lillisignificantly slowed the progression of the mind-numbing disease, according to clinical trial data released by the company on Wednesday. Patients…
-
Pfizer (PFE) Quarterly Report 2023
Pfizer on Tuesday reported first-quarter sales and adjusted earnings that beat Wall Street expectations, despite a decline in sales attributed to lower demand for the company’s Covid vaccine. Shares of the pharmaceutical giant were largely unchanged on Tuesday. Shares are down more than 23% for the year through Monday’s close, putting the company’s market value…
-
Scientists are creating an AI system that focuses on changing ideas into textual content
Alex Huth (left), Shailee Jain (center) and Jerry Tang (right) prepare to collect brain activity data at the University of Texas Biomedical Imaging Center at Austin. The researchers trained their semantic decoder using dozens of hours of participants’ brain activity data collected in an fMRI scanner. Photo: Nolan Zuk/University of Texas at Austin. Scientists have…
-
Sufferers might wait years for brand new medication
Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out more broadly in the coming years, putting them at risk of developing more severe disease as they wait months or perhaps years for a diagnosis. The U.S. health-care system is…
-
Eli Lilly weight reduction drug tirzepatide knowledge launched
patients who have taken Eli Lilli‘s weight-loss drug, Tirzepatide, lost an average of up to 34 pounds, or 16% of her body weight, the company said in clinical trial results released Thursday. Eli Lilly plans to complete its application for approval of the drug by the Food and Drug Administration in the coming weeks, and…